FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Pharmaceutical composition based on fucoidan for oral use made in the form of tablets, and a process for its preparation is described. Compositions include, as auxiliary substances, the following components at a ratio, mass %: fucoidan 33–37, fillers 50–60, mixture of disintegrants 4.0–10.0, glidants 0.5–10, lubricants 0.5–1. Process for preparing the composition comprises sequentially mixing the fillers with a mixture of disintegrants and a glidant, adding fucoidan, moistening the resulting mixture, wet granulation, drying at 40–45 °C, repeated granulation, lubrication with lubricants, tableting.
EFFECT: claimed invention provides increased bioavailability of fucoidan in tablets.
7 cl, 4 dwg, 3 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL ANTI-DIABETIC COMPOSITION OF PROLONGED ACTION | 2011 |
|
RU2465896C2 |
SYSTEM FOR DELIVERY OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR ORAL ADMINISTRATION IN FORM OF GASTRORETENTIVE TABLET | 2019 |
|
RU2734970C1 |
DOSAGE FORM IN CAPSULE FORM CONTAINING TABLETS WITH DIMETHYL FUMARATE | 2019 |
|
RU2742745C1 |
SUSTAINED-ACTION PHARMACEUTICAL COMPOSITION FOR TREATING HEART DISEASES | 2011 |
|
RU2464018C1 |
METHOD FOR PREVENTION OF DESULPHATION AND HIGH BIOAVAILABILITY OF BIOLOGICALLY ACTIVE SULPHATED ORAL POLYSACCHARIDES | 2009 |
|
RU2421230C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A KATP CHANNEL BLOCKER, METHOD FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2772875C1 |
NANODISPERSE COENZYME Q10 COMPOSITION AND METHOD FOR MAKING THEREOF | 2009 |
|
RU2411027C1 |
PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND, CONTAINING A GLUCOKINASE ACTIVATOR AND AN ALPHA-GLUCOSIDASE INHIBITOR, METHODS FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2775603C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE | 2019 |
|
RU2781638C2 |
USE OF 1-(2-(1N-IMIDAZOL-4-YL)ETHYL)PIPERIDINE-2,6-DIONE FOR TREATING COUGH CAUSED BY VIRAL INFECTIONS | 2022 |
|
RU2819722C2 |
Authors
Dates
2018-06-14—Published
2017-05-02—Filed